Historical record - last NADAC publication: 6/21/2017
Product Information
ZEPATIER 50-100 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $634.2375 per EA under NDC 00006307402. Its NADAC has been published 52 times since Jun 21, 2017.
Strength
50; 100 mg/1; mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006307402
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/21/2017
Active Ingredients
ELBASVIR; GRAZOPREVIR ANHYDROUSApproval Type
New Drug (NDA)
FDA Application
NDA208261On Market Since
1/28/2016
Pharmacological Classes
Price Statistics
The NADAC for ZEPATIER 50-100 MG TABLET has been published 52 times since Jun 21, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $634.2375 per EA |
|---|---|
| All-time high | $634.2375 (Jun 13, 2018) |
| All-time low | $634.2375 (Jun 21, 2017) |
| Median price | $634.2375 |
| Average price | $634.2375 |
| Largest weekly change | 0.0% (Jun 28, 2017) |
| Weeks tracked | 52 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the elbasvir and grazoprevir market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZEPATIER 50-100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZEPATIER 50-100 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $634.2375 per EA (NDC 00006307402), effective Jun 13, 2018.
How has the price of ZEPATIER 50-100 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZEPATIER 50-100 MG TABLET has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for ZEPATIER 50-100 MG TABLET?
Since Jun 21, 2017, the NADAC for ZEPATIER 50-100 MG TABLET has ranged from a low of $634.2375 (Jun 21, 2017) to a high of $634.2375 (Jun 13, 2018), with a median of $634.2375 per EA.
Are there cheaper alternatives to ZEPATIER 50-100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZEPATIER 50-100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ZEPATIER 50-100 MG TABLET?
ZEPATIER 50-100 MG TABLET (NDC 00006307402) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification